Sato Yuji, Koyama Keisuke
Centre for Clinical Research, School of Medicine, Keio University, Tokyo, Japan.
Keio J Med. 2010;59(3):104-9. doi: 10.2302/kjm.59.104.
The volume of clinical research carried out in Japan is relatively small by global standards, especially when compared with the country's contributions to basic research. Although the academic quality of the clinical research done here is generally high, its relative paucity has had a number of alarming consequences, e.g., delays in the approval of important new drugs and medical devices caused by difficulties in clinical trials, leading to the limited availability of novel treatments for Japanese patients. This article aims to present an overview of current clinical research activities in Japan and to summarise the historical, socio-cultural and regulatory issues underlying the current situation. Suggestions are made as to how the present problems might be resolved and how a brighter future for clinical research might be achieved.
按照全球标准,日本开展的临床研究规模相对较小,尤其是与该国在基础研究方面的贡献相比。尽管这里开展的临床研究学术质量总体较高,但其数量相对较少已产生了一些令人担忧的后果,例如,临床试验困难导致重要新药和医疗器械的审批延迟,从而使日本患者能够获得的新型治疗方法有限。本文旨在概述日本当前的临床研究活动,并总结当前形势背后的历史、社会文化和监管问题。针对如何解决当前问题以及如何实现临床研究更光明的未来提出了建议。